• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, December 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Ruben van Boxtel receives prestigious NYSCF Robertson Stem Cell Investigator Award

Bioengineer by Bioengineer
October 18, 2022
in Cancer
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Van Boxtel says, ‘I am tremendously honored to have received the NYSCF Robertson Stem Cell Investigator award and grateful for this opportunity to accelerate my research.’ Van Boxtel’s research focuses on unraveling the origins of late effects of treatment in children who had blood cancer and what role stem cells play in it. ‘If we properly understand how these arise then that brings us a big step closer to finding a solution to prevent these effects. It also creates the possibility of predicting the likelihood of late effects prior to treatment and adjusting treatment accordingly.’

Dr. Ruben van Boxtel

Credit: Marloes Verweij, Laloes Fotografie

Van Boxtel says, ‘I am tremendously honored to have received the NYSCF Robertson Stem Cell Investigator award and grateful for this opportunity to accelerate my research.’ Van Boxtel’s research focuses on unraveling the origins of late effects of treatment in children who had blood cancer and what role stem cells play in it. ‘If we properly understand how these arise then that brings us a big step closer to finding a solution to prevent these effects. It also creates the possibility of predicting the likelihood of late effects prior to treatment and adjusting treatment accordingly.’

Follow-up on research leads

Research using cell cultures and mice provides insight into how stem cells can repair damaged tissues. Van Boxtel has also found possible leads for how this works in people by examining stem cells after chemotherapy in addition to transplanted stem cells. ‘Thanks to this award, we can continue this research. For example, we suspect, thanks to examining the blood system of chemotherapy-treated children, that some stem cells appear ‘stronger’ than other stem cells and are better able to generate new blood. It is therefore possible that ‘super stem cells’ exist. This would be an important discovery not only for the treatment of children with blood cancer, but also for many other diseases involving regenerative medicine using stem cells.

One and one is three

By winning the NYSCF Robertson Stem Cell Investigator Award, Van Boxtel joins a network of internationally prominent researchers in the field of stem cell biology and regenerative medicine. ‘Knowledge exchange and collaboration is crucial to achieving breakthroughs. It gives you new ideas because together you look at your research and outcomes from different perspectives. It is also enormously inspiring to combine knowledge and strengths with colleagues. This prize is therefore really a great accelerator and example of how one and one becomes three.’

Previously, Van Boxtel also received the ERC Consolidator grant and the Ammodo Science Award for groundbreaking research.

About late effects in survivors:
Children with cancer are often treated with chemotherapy at the Princess Máxima Center. In some cases, they also receive a stem cell transplant in addition. These forms of treatment have proven successful and on total average three out of four children are cured. However, an adverse consequence of these treatments is that not only are the cancer cells destroyed, but in some children healthy tissues are also damaged. This causes adverse late effects in these children later in life.

About Dr. Ruben van Boxtel:
Ruben van Boxtel has pioneered the development of experimental and computational approaches to study somatic mutations in healthy human stem cells. His group was the first to show how mutations accumulate in different tissues throughout human life and how this can contribute to cancer (Blokzijl et al., Nature 2016). In 2017, Ruben was appointed as a group leader at the Princess Máxima Center for Pediatric Oncology, where he focusses on studying why children can develop cancer and what the genotoxic effects of treatment are in normal tissues. Using in-depth mutational analyses, the group of Ruben has discovered mutational cancer signatures caused by a common gut bacterium (Pleguezuelos-Manzano et al., Nature 2020), antiviral drugs (de Kanter et al., Cell Stem Cell) or certain chemotherapeutic drugs (Bertrums et al., Cancer Discovery 2022). 

Ruben has obtained several prestigious grants and awards for cancer and stem cell research from various organizations, such as the Netherlands Organization for Scientific Research (NWO) and the European Research Counsel (ERC), including the NWO VIDI (2017) and ERC Consolidator (2019) grants. In 2019, he was selected as an Oncode Investigator, which a collective institute bringing together the best fundamental cancer researchers in the Netherlands.

About the Princess Máxima Center for pediatric oncology

When a child is seriously ill from cancer, only one thing matters: a cure. 

That is why at the Princess Máxima Center for pediatric oncology, we work together with passion, pushing the boundaries to improve survival and quality of life for children with cancer. Now, and in the long term. Because children have their entire lives ahead of them. 

The Princess Máxima Center for pediatric oncology is no ordinary hospital but a research hospital, the biggest childhood cancer center in Europe. Here, more than 400 scientists and 900 healthcare professionals work closely with Dutch and international hospitals to find new treatments and new perspectives for a cure. 

In this way, we offer children today the very best care, and take important steps toward improving survival for the children who are not yet cured.



Share12Tweet8Share2ShareShareShare2

Related Posts

Mutated protein associated to recycling regulation

Leukemia cells activate cellular recycling program

December 4, 2023
Highly aggressive cell carcinomas

Mathematics supporting fresh theoretical approach in oncology

December 4, 2023

Training the immune system to prevent cancer – NextGen researchers discover paradigm-shifting approach

December 4, 2023

Immunotherapy added to first-line standard therapy significantly improves survival in metastatic or recurrent cervical cancer

December 4, 2023

POPULAR NEWS

  • Figure 1

    Understanding rapid tendon regeneration in newts may one day help human athletes

    85 shares
    Share 34 Tweet 21
  • Study finds increasingly popular oral nicotine pouches do little to curb smokers’ cravings

    35 shares
    Share 14 Tweet 9
  • SMART researchers pioneer novel microfluidic method to optimise bone marrow stem cell extraction for advanced cell therapies

    34 shares
    Share 14 Tweet 9
  • UMass Amherst receives $2.5 million from Howard Hughes Medical Institute to reshape STEM education

    34 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Leukemia cells activate cellular recycling program

Mathematics supporting fresh theoretical approach in oncology

Georgia State professor granted $5 million to identify and characterize objects in space

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 58 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In